Man Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Man Group’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,735,565	Closed	-$14.1M	–	2033
2019 Q2	$14.1M	Buy	+2,735,565	New	+$12.3M	0.05%	481
2019 Q1	–	Sell	-34,310	Closed	-$210K	–	2145
2018 Q4	$210K	Buy	34,310 +18,610	+119%	+$114K	﹤0.01%	1807
2018 Q3	$92K	Sell	15,700 -6,000	-28%	-$30K	﹤0.01%	2052
2018 Q2	$92K	Buy	+21,700	New	+$109K	﹤0.01%	2074

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Man Group's PETX Position: Q3 2019 in Review

Man Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 2,735,565 shares — an estimated $14.1M sold.

Man Group first reported a position in PETX in Q2 2018 and held it in 4 quarters. The position peaked at $14.1M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Man Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Man Group sold 2,735,565 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $14.1M.
Man Group first reported a position in Aratana Therapeutics, Inc. in Q2 2018 and held it in 4 quarters.
Man Group's Aratana Therapeutics, Inc. position peaked at $14.1M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Man Group's 13F filing for Q3 2019, filed 14 Nov 2019.